Everforth Inc quarterly report, Q1 FY2012

Business context and reporting period

The filing is On Assignment, Inc.’s unaudited Form 10-Q for the quarter ended March 31, 2012. The company provides staffing and placement services through Life Sciences, Healthcare, Physician, and IT and Engineering segments. The request metadata names Everforth Inc.; the filing itself identifies On Assignment, Inc., so the issuer identity should be verified.

Financial results and liquidity

MetricQ1 2012Q1 2011
Revenue$167.1 million$129.4 million
Gross profit / margin$55.0 million / 32.9%$43.2 million / 33.3%
Operating income / margin$9.9 million / 6.0%$6.4 million / 4.9%
Net income$5.4 million$3.2 million
Diluted EPS$0.14$0.08
Operating cash flow$7.0 million$5.8 million

Revenue rose 29.1%; gross profit increased 27.6%, while gross margin contracted about 39 basis points. SG&A rose 22.7% to $45.1 million, including $2.5 million of costs primarily related to the pending Apex acquisition. The effective tax rate was 41.8%, versus 44.4%.

At March 31, cash was $17.7 million, including $8.4 million held abroad that the company said it did not intend to repatriate. Working capital was $75.8 million. Debt totaled $80.5 million ($5.0 million current and $75.5 million long-term), down from $86.8 million at year-end; the company reported compliance with its debt covenants. Total assets were $420.0 million and total liabilities $164.0 million. Q1 investing cash use was $2.1 million, including $2.1 million of capital expenditures; management estimated full-year 2012 capital expenditures of approximately $8.0 million. Cash decreased $0.1 million during the quarter.

Material changes and management commentary

Management attributed $26.5 million of revenue growth to organic growth and $11.1 million to acquisitions. IT and Engineering generated the largest segment revenue increase ($18.6 million, or 31.0%); Physician revenue grew 45.8%, including $6.6 million from HCP. All four segments grew. Management said demand strengthened across the segments and described continued improvement in healthcare demand, while noting that Healthcare remained soft.

On March 20, 2012, the company agreed to acquire Apex Systems for $217 million in On Assignment shares and $383 million in cash, subject to adjustments and closing conditions, including shareholder approval and debt financing. The transaction was expected to close in Q2 2012. A committed $540 million senior secured facility would fund the cash consideration, repay existing On Assignment and Apex debt, and cover transaction expenses. The filing does not provide completed acquisition results or a formal earnings forecast.

Outlook, risks, contingencies, and unusual items

  • Management said working capital, the existing credit facility, and expected operating cash flows should cover obligations and planned capital expenditures for the next 12 months; completion of the Apex deal would add significant capital commitments.
  • The company identified economic uncertainty, demand for staffing services, recruiting and retention, competition, professional availability, growth management, and information-system performance as risks. It also cited integration and substantial indebtedness risks if the Apex deal closes.
  • If the merger terminates in specified circumstances, a $21.0 million fee may be payable to Apex. Potential acquisition earn-outs were approximately $10.4 million through 2013. Workers’ compensation and medical malpractice reserves were approximately $10.2 million; letters of credit securing claims were $2.4 million.
  • Management said pending ordinary-course legal matters were not expected to materially affect financial position, results, or cash flows. No interim goodwill impairment trigger was identified. The company had an interest-rate swap liability of $0.6 million and expected to reclassify $0.3 million of pretax losses to interest expense over the next 12 months.
  • Staffing demand is typically seasonally lower in Q1 and Q4; payroll taxes also generally reset higher in Q1. Management reported effective disclosure controls and no material quarterly change in internal control over financial reporting.

Important facts for investors to verify

  • Confirm that the filing issuer, On Assignment, Inc., is the intended company, given the Everforth Inc. metadata.
  • Check Apex merger closing conditions, financing terms, final purchase consideration, and whether the transaction closed as expected.
  • Assess the effect of the proposed $540 million financing on pro forma leverage, interest expense, covenants, and liquidity.
  • Monitor whether organic growth, segment demand, and margins—particularly in Healthcare and Physician—continue to develop as management described.
  • Review acquisition earn-out estimates, self-insurance reserves, foreign cash availability, and the potential merger termination fee.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.